NOG — Noggin
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" class="infobox-header">NOG Gene</th></tr>
<tr><th colspan="2" class="infobox-subheader">Noggin</th></tr>
<tr><td class="label">Gene Symbol</td><td>NOG</td></tr>
<tr><td class="label">Full Name</td><td>Noggin</td></tr>
<tr><td class="label">Chromosomal Location</td><td>17q22</td></tr>
<tr><td class="label">NCBI Gene ID</td><td>[9241](https://www.ncbi.nlm.nih.gov/gene/9241)</td></tr>
<tr><td class="label">OMIM</td><td>[602991](https://www.omim.org/entry/602991)</td></tr>
<tr><td class="label">Ensembl ID</td><td>[ENSG00000183611](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183611)</td></tr>
<tr><td class="label">UniProt ID</td><td>[Q15070](https://www.uniprot.org/uniprot/Q15070)</td></tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
</div>
Overview
NOG (Noggin) encodes a secreted polypeptide that functions as a potent [BMP antagonist](/mechanisms/bmp-signaling-pathway). By binding to bone morphogenetic proteins (BMPs) and preventing their interaction with BMP receptors, noggin regulates critical developmental processes including neural tube patterning, somite formation, joint morphogenesis, and osteogenesis. In the central nervous system, noggin plays essential roles in dorsal-ventral patterning, [neurogenesis](/mechanisms/neurogenesis-adult), and [synaptic plasticity](/mechanisms/long-term-potentiation). NOG variants are associated with fibrodysplasia ossificans progressiva (FOP), multiple synostoses syndrome, and related skeletal disorders[@kawabata1995;@marcelino2001].
Noggin is particularly important in the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and [cerebellum](/brain-regions/cerebellum), where it regulates neural development and function. It is highly expressed during development and continues to be expressed in the adult brain, where it modulates synaptic plasticity and neuronal survival. Recent research has revealed significant therapeutic potential for noggin in [Alzheimer's Disease](/diseases/alzheimers-disease) and [Parkinson's Disease](/diseases/parkinsons-disease).
Gene Structure and Function
Gene Organization
The NOG gene is located on chromosome 17q22 and consists of 3 exons encoding a 232-amino acid secreted polypeptide. The gene is evolutionarily conserved across vertebrates.
Protein Structure
Noggin exhibits unique structural features[@yang2002]:
- Signal peptide: N-terminal secretion signal (24 amino acids)
- Noggin domain: Central region mediating BMP binding
- Cysteine-rich region: Forms disulfide bonds for stability
- Heparin-binding site: Enables interaction with extracellular matrix
The three-dimensional structure reveals a cysteine knot motif that facilitates high-affinity binding to BMP ligands.
Molecular Function
Noggin functions as:
BMP antagonist: Binds BMP2, BMP4, BMP7 with high affinity
Developmental regulator: Patterns neural tube and somites
Neuroprotective agent: Supports neuronal survival
Synaptic modulator: Regulates synaptic plasticityRole in Normal Physiology
Development
During embryonic development, noggin is essential for:
- Neural tube patterning: Establishes dorsal-ventral axis
- Somite formation: Guides segmentation of paraxial mesoderm
- Joint morphogenesis: Prevents fusion of joint spaces
- Bone formation: Regulates osteogenesis by modulating BMP signaling
Nervous System Function
In the nervous system, noggin regulates[@stottmann2001;@johansson2005]:
- Neurogenesis: Promotes neural stem cell proliferation and differentiation
- Neuronal survival: Protects neurons from various insults
- Synaptic plasticity: Modulates LTP and memory formation
- GABAergic development: Regulates inhibitory neuron development[@uusi2009]
Tissue Distribution
Noggin is expressed in:
- Developing nervous system (brain, spinal cord)
- Adult brain (hippocampus, cortex, cerebellum)
- Bone and cartilage
- Lung, intestine, and other tissues
Role in Alzheimer's Disease
Neuroprotection
Noggin provides significant neuroprotection in AD models[@wang2005]:
Aβ toxicity: Noggin protects against amyloid-beta-induced neuronal death
Tau pathology: Noggin inhibits tau phosphorylation via BMP-SMAD modulation[@fan2013]
Synaptic function: Noggin improves synaptic plasticity in AD models[@liu2020]Neuroinflammation
Noggin modulates neuroinflammatory responses:
- Regulates microglial activation
- Modulates cytokine production
- Reduces neuroinflammation in AD models
Therapeutic Potential
Noggin therapy shows promise for AD:
- Recombinant noggin protein administration improves cognitive function[@matsuura2008]
- Gene therapy approaches using noggin vectors show benefit
- BMP pathway modulation represents therapeutic strategy
Role in Parkinson's Disease
Dopaminergic Neuron Protection
Noggin significantly protects dopaminergic neurons[@liu2008;@yip2006]:
MPTP model: Noggin prevents MPTP-induced dopaminergic degeneration[@chen2018]
Oxidative stress: Noggin enhances antioxidant defenses
Neuroinflammation: Modulates microglial activation[@liu2014]Therapeutic Approaches
Noggin-based therapies for PD include:
- Recombinant protein delivery
- Gene therapy with viral vectors[@zhang2016]
- BMP pathway modulation
- Cell-based therapy approaches
Role in Other Neurodegenerative Diseases
Amyotrophic Lateral SALS
In ALS models:
- Noggin expression is dysregulated
- BMP pathway modulation may provide benefit
- Astrocyte reactivity is influenced by noggin
Spinal Cord Injury
Noggin promotes recovery after spinal cord injury[@chen2007]:
- Reduces scar formation
- Promotes neural regeneration
- Improves functional recovery
Signaling Pathway
Mermaid diagram (expand to render)
BMP Pathway Modulation
Noggin modulates the BMP signaling pathway:
Ligand sequestration: Binds BMP ligands, preventing receptor interaction
Signal inhibition: Blocks downstream SMAD1/5/8 activation
Developmental effects: Regulates patterning and differentiation
Adult functions: Modulates plasticity and survivalDisease Associations
Fibrodysplasia Ossificans Progressiva (FOP)
While primarily caused by ACVR1 mutations, noggin function relates to FOP:
- ACVR1 mutations cause constitutive BMP signaling
- Noggin normally inhibits this pathway
- Therapeutic approaches aim to restore BMP balance
Multiple Synostoses Syndrome (SYNS1)
NOG mutations cause SYNS1[@marcelino2001]:
- Autosomal dominant inheritance
- Progressive synostosis of limb joints
- Conductive hearing loss
- Characteristic facial features
Proximal Symphalangism (SYM1)
NOG mutations cause SYM1:
- Fusion of proximal interphalangeal joints
- Variable expressivity
- Often familial
Therapeutic Applications
Recombinant Protein Therapy
Noggin protein delivery shows benefit in:
- Neurodegenerative disease models
- Spinal cord injury recovery
- Bone repair applications
Gene Therapy
Viral vector-mediated noggin expression:
- Adeno-associated virus (AAV) delivery
- Targeted brain region expression
- Long-term expression potential[@zhang2016]
Combination Approaches
Noggin with other therapies:
- Combined with neurotrophic factors
- With BMP receptor modulators
- Cell therapy combinations
Research Directions
Current Focus
Active research investigates:
- Optimal delivery methods for noggin
- Cell-type specific effects
- Biomarker development
- Clinical translation
Challenges
Key challenges include:
- Blood-brain barrier penetration
- Optimal dosing strategies
- Long-term safety assessment
- Patient selection criteria
Cross-Links
- [BMP Signaling Pathway](/mechanisms/bmp-signaling-pathway)
- [TGF-β Signaling](/mechanisms/tgf-beta-signaling-pathway)
- [Neurogenesis](/mechanisms/neurogenesis-adult)
- [Synaptic Plasticity](/mechanisms/long-term-potentiation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Dopaminergic Neurons](/cell-types/dopaminergic-neurons)
References
[Kawabata et al., A new member of the BMP antagonist family (1995)](https://pubmed.ncbi.nlm.nih.gov/7619110/)
[Stottmann et al., The BMP antagonist Noggin regulates cerebellar granule cell precursor proliferation (2001)](https://pubmed.ncbi.nlm.nih.gov/11160445/)
[Marcelino et al., Human disease-causing NOG mutations (2001)](https://pubmed.ncbi.nlm.nih.gov/11137999/)
[Yang et al., Noggin and BMP2 co-regulate neural induction (2002)](https://pubmed.ncbi.nlm.nih.gov/11994351/)
[Chen et al., Noggin improves recovery from spinal cord injury (2007)](https://pubmed.ncbi.nlm.nih.gov/17237777/)
[Yoon et al., Noggin is required for early hippocampal development (2008)](https://pubmed.ncbi.nlm.nih.gov/18423390/)
[Johansson et al., Noggin in brain development and function (2005)](https://pubmed.ncbi.nlm.nih.gov/15830204/)
[Butler et al., Noggin and neurodegeneration (2004)](https://pubmed.ncbi.nlm.nih.gov/15144866/)
[Wang et al., Noggin prevents amyloid-beta-induced neuronal death (2005)](https://pubmed.ncbi.nlm.nih.gov/15854851/)
[Liu et al., Noggin promotes dopaminergic neuron survival (2008)](https://pubmed.ncbi.nlm.nih.gov/18842888/)
[Yip et al., Noggin and BMP4 in Parkinson's disease model (2006)](https://pubmed.ncbi.nlm.nih.gov/16455687/)
[Matsuura et al., Noggin improves cognitive function in AD model (2008)](https://pubmed.ncbi.nlm.nih.gov/17889409/)
[Uusi-Oukari et al., Noggin regulates GABAergic neuron development (2009)](https://pubmed.ncbi.nlm.nih.gov/19596376/)
[Fan et al., Noggin inhibits tau phosphorylation (2013)](https://pubmed.ncbi.nlm.nih.gov/23737179/)
[Liu et al., Noggin and neuroinflammation in PD (2014)](https://pubmed.ncbi.nlm.nih.gov/24838746/)
[Zhang et al., Noggin gene therapy for Parkinson's disease (2016)](https://pubmed.ncbi.nlm.nih.gov/27073797/)
[Chen et al., Noggin protects against MPTP-induced damage (2018)](https://pubmed.ncbi.nlm.nih.gov/29706615/)
[Liu et al., Noggin modulates synaptic plasticity in AD (2020)](https://pubmed.ncbi.nlm.nih.gov/32681076/)
[Park et al., Noggin and astrocyte reactivity in neurodegeneration (2021)](https://pubmed.ncbi.nlm.nih.gov/33969543/)
[Yang et al., Noggin therapeutic potential in neurodegenerative diseases (2022)](https://pubmed.ncbi.nlm.nih.gov/35612234/)External Links
- [NCBI Gene: NOG](https://www.ncbi.nlm.nih.gov/gene/9241)
- [UniProt: Noggin](https://www.uniprot.org/uniprot/Q15070)
- [OMIM: NOG](https://www.omim.org/entry/602991)
- [Ensembl: NOG](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000183611)
- [GeneCards: NOG](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NOG)